peptide-based liquid droplets as emerging delivery vehicles Peptides - the-ordinary-serum-multi-peptides-pour-cils-et-sourcils-5ml peptide based Peptide-Based Liquid Droplets: Emerging Vehicles Revolutionizing Delivery Systems

tb500-peptide-and-bpc-157 The field of therapeutic and clinical applications is increasingly dominated by protein and peptide-based pharmaceuticalsMaking peptides - Spiral. However, the efficient delivery of these valuable biomolecules has historically presented significant challenges作者：J Liu·2023·被引用次数：106—Peptide-based microdroplets create new opportunities for deliverycompared with other types of delivery vehicle, such as lipid and polymer .... Traditional parenteral administration, while orthodox, often falls short in achieving targeted and controlled release. Fortunately, a groundbreaking advancement is emerging: peptide-based liquid droplets as emerging delivery vehicles. These innovative constructs, formed through a phenomenon known as liquid-liquid phase separation (LLPS), are poised to revolutionize how we deliver a wide range of therapeutic agents.Peptide-based coacervates in therapeutic applications

At the core of this innovation are peptides, which are short chains of amino acids. When designed with specific properties, these peptides can self-assemble into dynamic structures that mimic natural biological condensates.Disulfide cross-linked redox-sensitive peptide condensates ... These condensates are dynamic liquid droplets, often referred to as coacervate droplets, which form through the spontaneous separation of a solution into distinct liquid phases. This process, driven by intermolecular interactions, allows for the encapsulation and controlled release of various payloads.

Peptide-based microdroplets are creating new opportunities for delivery compared to established methods like lipid nanoparticles and polymer-based systems. The inherent biocompatibility and biodegradability of peptides make them particularly attractive for biomedical applications. Researchers are actively exploring recent progress in the design of liquid-like microdroplets, focusing on tailoring peptide sequences to achieve specific properties such as stability, responsiveness, and targeting capabilities.作者：J Liu·2023·被引用次数：106—This Comment highlightsrecent progress in the design of liquid-like microdroplets, or coacervates, based on peptides and produced through liquid-liquid phase ...

One of the key advantages of peptide-based liquid droplets lies in their versatilityA class ofdelivery vehicles basedon pH-sensitive, water soluble membranepeptides, pHLIPs, that target cells located in an acidic microenvironment found .... They can serve as effective delivery vehicles for a broad spectrum of molecules, including small drugs, nucleic acids, and even other proteins. This makes them incredibly valuable for applications ranging from gene therapy to targeted cancer treatments.This Comment highlightsrecent progress in the design of liquid-like microdroplets, or coacervates, based on peptides and produced through liquid–liquid phase ... For instance, peptide-based condensates can be engineered to respond to specific environmental cues within the body, such as pH changes or enzymatic activity, triggering the release of their cargo precisely where it's needed.作者：S Song·被引用次数：25—Biomolecularcondensates are dynamic liquid dropletsthrough intracellular liquid-liquid phase separation that function as membraneless organelles. This level of control minimizes off-target effects and enhances therapeutic efficacy作者：C Yuan·2023·被引用次数：136—This review focuses on the latest studies of LLPS-mediatedpeptideself-assembly and explores the thermodynamic and kinetic mechanisms responsible for this non ....

The scientific community is witnessing significant advancements in this area. Recent reviews highlight recent developments in peptide-based LLPS, detailing various strategies for designing peptide sequences that promote efficient phase separation and droplet formation. These peptide-based biomimetic condensates leverage nature's own mechanisms for compartmentalization and transport within cells, offering a biomimetic approach to drug delivery.

Furthermore, coacervate droplets have emerged as intracellular delivery vehicles, opening doors for direct delivery of therapeutics into cells作者：J Liu·2023·被引用次数：106—This Comment highlightsrecent progress in the design of liquid-like microdroplets, or coacervates, based on peptides and produced through liquid-liquid phase .... While the exact internalization mechanisms are still under investigation, their ability to encapsulate and deliver molecules directly into the cellular environment is a major breakthroughEngineering protein andpeptide-basedmaterials for drugdeliveryapplications has gained momentum due to their biochemical and biophysical properties over .... This is particularly relevant for delivering drugs that need to reach specific organelles or intracellular targets.

The design of these peptide-based liquid droplets is continuously evolving.Peptide-Based Biomimetic Condensates via Liquid- ... Researchers are exploring different types of peptide-based coacervates, including those stabilized by various interactions like cation-π interactions, which are crucial in expanding their biomedical applicationsRedox-responsive peptide-based complex coacervates as .... Additionally, disulfide cross-linked redox-sensitive peptide condensates are being developed, offering reversible formation and dissolution under specific redox conditions, further enhancing their utility as celldelivery vehicles.

The potential applications extend beyond traditional drug deliveryA class ofdelivery vehicles basedon pH-sensitive, water soluble membranepeptides, pHLIPs, that target cells located in an acidic microenvironment found .... Liquid droplets are being explored as novel biomaterials in diagnostics and immunomodulation作者：Y Sun·2024·被引用次数：43—Phase-separatingpeptides(PSPs) self-assembling into coacervate micro-droplets(CMs) are a promising class of intracellulardelivery vehicles.... The ability to create programmable phase-separating peptide coacervates with tunable properties allows for the development of sophisticated delivery systems tailored to specific therapeutic needs.

In summary, peptide-based liquid droplets represent an exciting and rapidly advancing frontier in delivery. Their unique properties, stemming from peptide self-assembly and liquid-liquid phase separation, offer a promising alternative to existing delivery systems. As research continues to uncover new design strategies and applications, these emerging delivery vehicles are set to play a pivotal role in the future of medicine, offering enhanced efficacy, targeted delivery, and improved patient outcomes for a new generation of peptide-based therapeutics.